Try our Advanced Search for more refined results
JAZZ PHARMACEUTICALS, INC. v. ROXANE LABORATORIES, INC.
Case Number:
2:10-cv-06108
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
June 19, 2015
Roxane Can Fix Arguments In Jazz's Xyrem Patent Suit
A New Jersey federal judge denied Jazz Pharmaceuticals Inc.'s appeal of an order allowing Roxane Laboratories Inc. to amend its invalidity and noninfringement arguments in a suit over a planned generic of Jazz's narcolepsy drug Xyrem, saying Friday the amendments are timely.
-
June 25, 2014
Drug Challenged Under AIA Biz Method Review For 1st Time
Amneal Pharmaceuticals LLC and others asked the Patent Trial and Appeal Board on Tuesday to invalidate a patent for distribution of Jazz Pharmaceuticals Inc.'s narcolepsy drug Xyrem as an abstract idea, the first time the America Invents Act's business method review program has been used in a drug case.